Indiana
|
0-23357
|
35-1345024
|
||
(State
or other jurisdiction
of
incorporation or
organization)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification
No.)
|
2701
KENT AVENUE
WEST
LAFAYETTE, INDIANA
|
47906-1382
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act(17CFR240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange
Act(17CFR240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act(17CFR240.13e-4(c))
|
|
10.1
|
Fifth
Amendment to Amended and Restated Credit Agreement between Bioanalytical
Systems, Inc. and PNC Bank, as successor to National City Bank, executed
December 31, 2009.
|
BIOANALYTICAL
SYSTEMS, INC.
|
|||
Date:
December 31, 2009
|
By:
|
/s/
Michael R. Cox
|
|
Michael
R. Cox
|
|||
Vice
President, Finance and Administration,
|
|||
Chief
Financial Officer and
Treasurer
|
Exhibit No.
|
Description
|
|
10.1
|
Fifth
Amendment to Amended and Restated Credit Agreement between Bioanalytical
Systems, Inc. and PNC Bank, as successor to National City Bank, executed
December 31, 2009.
|